	Lngresos Netos		Fecha
Acadia Pharmaceuticals	USD 273.57M	201.79M	2025-12
Agios Pharmaceuticals	USD -108.04M	4.61M	2025-12
Alnylam Pharmaceuticals	USD 186.42M	64.66M	2025-12
Amarin	USD -7.74M	6.4M	2025-09
Amgen	USD 1.33B	1.88B	2025-12
Baxter International	USD -1.13B	1.08B	2025-12
Cara Therapeutics	USD -4.91M	2.77M	2025-03
Cytokinetics	USD -183.03M	123.15M	2025-12
DBV Technologies	USD -33.16M	8.71M	2025-09
Eli Lilly	USD 6.64B	1.05B	2025-12
Esperion Therapeutics	USD -29.52M	32.4M	2024-09
Halozyme Therapeutics	USD -141.59M	316.82M	2025-12
Ionis Pharmaceuticals	USD -229M	100.39M	2025-12
MannKind	USD -15.95M	23.93M	2025-12
Minerva Neurosciences	USD 1.44M	21.07M	2024-12
Nektar Therapeutics	USD -37.06M	15.31M	2024-09
Pfizer	USD -1.65B	5.19B	2025-12
Rigel Pharmaceuticals	USD 12.42M	13.45M	2024-09
United Therapeutics	USD 364.3M	25.6M	2025-12
Vanda Pharmaceuticals	USD -18.9M	13.58M	2024-12

Halozyme Therapeutics Lngresos Netos - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2026.